Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Dec. 22, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

Penederm and Mylan to copromote Mentax

Dec. 22, 1997

Oral neuraminidase inhibitor advances to phase II/III

Dec. 19, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

Pentose receives U.S. and European patent allowances for Papirine compounds

Dec. 18, 1997

Potent, broad-spectrum carbapenem discovered at Fujisawa

Dec. 18, 1997

Millennium/Pfizer antifungal collaboration expanded

Dec. 17, 1997

Faropenem data presented at Japanese congress

Dec. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...